Role of TRAILR1 and TNFR1A polymorphisms in the susceptibility and pharmacogenetics of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.